| JPM SGD LIQUIDITY LVNAV C (ACC) | RFI ASIA PACÍFICO EX-JAPÓN | 7.898,405621 | 28/08/2026 | 2,78% | 6,39% | *** |
| JPM SGD LIQUIDITY LVNAV C (DIST) | RFI ASIA PACÍFICO EX-JAPÓN | 0,675584 | 28/08/2026 | 2,05% | -0,97% | * |
| JPM SGD LIQUIDITY LVNAV CORE (DIST) | RFI ASIA PACÍFICO EX-JAPÓN | 0,675584 | 28/08/2026 | 2,05% | · | ND |
| JPM SGD LIQUIDITY LVNAV E (ACC) | RFI ASIA PACÍFICO EX-JAPÓN | 7.567,565194 | 28/08/2026 | 2,85% | 6,73% | *** |
| JPM SGD LIQUIDITY LVNAV E (DIST) | RFI ASIA PACÍFICO EX-JAPÓN | 0,675584 | 28/08/2026 | 2,05% | -0,97% | * |
| JPM SGD LIQUIDITY LVNAV INSTITUTIONAL (DIST) | RFI ASIA PACÍFICO EX-JAPÓN | 0,675584 | 28/08/2026 | 2,05% | -0,97% | * |
| JPM TAIWAN A (ACC) EUR | RVI CHINA | 118,190000 | 28/08/2026 | 77,17% | 188,55% | ***** |
| JPM TAIWAN A (ACC) USD | RVI CHINA | 93,730138 | 28/08/2026 | 77,52% | 188,61% | ***** |
| JPM TAIWAN A (DIST) USD | RVI CHINA | 67,078932 | 28/08/2026 | 77,52% | 178,31% | ***** |
| JPM TAIWAN C (ACC) USD | RVI CHINA | 123,327321 | 28/08/2026 | 78,53% | 196,07% | ***** |
| JPM TAIWAN C (DIST) USD | RVI CHINA | 476,071459 | 28/08/2026 | 78,51% | 179,82% | ***** |
| JPM TAIWAN D (ACC) USD | RVI CHINA | 71,201580 | 28/08/2026 | 76,35% | 180,14% | ***** |
| JPM TAIWAN I (ACC) EUR | RVI CHINA | 581,380000 | 28/08/2026 | 78,21% | 196,38% | ***** |
| JPM TAIWAN I (ACC) USD | RVI CHINA | 493,420940 | 28/08/2026 | 78,56% | 196,44% | ***** |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 122,244767 | 28/08/2026 | 19,24% | 25,88% | ** |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 125,610000 | 28/08/2026 | 21,50% | 31,53% | ** |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) USD | RVI BIOTECNOLOGÍA | 117,856223 | 28/08/2026 | 23,56% | 28,29% | ** |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 122,180692 | 28/08/2026 | 19,25% | 25,84% | ** |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 125,000000 | 28/08/2026 | 21,48% | 31,29% | ** |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) USD | RVI BIOTECNOLOGÍA | 117,263592 | 28/08/2026 | 23,52% | 28,03% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 126,847501 | 28/08/2026 | 19,69% | 27,99% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 129,790000 | 28/08/2026 | 21,94% | 33,53% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) GBP (HEDGED) | RVI BIOTECNOLOGÍA | 165,597294 | 28/08/2026 | 25,46% | 39,94% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) USD | RVI BIOTECNOLOGÍA | 121,764150 | 28/08/2026 | 23,99% | 30,22% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 125,512601 | 28/08/2026 | 19,69% | 26,80% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 128,400000 | 28/08/2026 | 21,93% | 32,30% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) GBP (HEDGED) | RVI BIOTECNOLOGÍA | 163,719085 | 28/08/2026 | 25,45% | 38,58% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) USD | RVI BIOTECNOLOGÍA | 120,424289 | 28/08/2026 | 23,98% | 28,97% | ** |
| JPM THEMATICS-GENETIC THERAPIES C (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 105,380000 | 28/08/2026 | 21,83% | 33,14% | ** |
| JPM THEMATICS-GENETIC THERAPIES C (ACC) USD | RVI BIOTECNOLOGÍA | 98,557073 | 28/08/2026 | 23,89% | 29,86% | ** |
| JPM THEMATICS-GENETIC THERAPIES C (DIST) GBP | RVI BIOTECNOLOGÍA | 97,515166 | 28/08/2026 | 23,57% | 28,29% | ** |
| JPM THEMATICS-GENETIC THERAPIES C (DIST) USD | RVI BIOTECNOLOGÍA | 70,548828 | 28/08/2026 | 23,89% | 28,73% | ** |
| JPM THEMATICS-GENETIC THERAPIES D (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 98,520000 | 28/08/2026 | 20,71% | 27,62% | ** |
| JPM THEMATICS-GENETIC THERAPIES D (ACC) USD | RVI BIOTECNOLOGÍA | 78,837069 | 28/08/2026 | 22,73% | 24,30% | ** |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 122,920000 | 28/08/2026 | 21,96% | 33,68% | ** |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) USD | RVI BIOTECNOLOGÍA | 89,178047 | 28/08/2026 | 24,02% | 30,37% | ** |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | RVI BIOTECNOLOGÍA | 87,300000 | 28/08/2026 | 23,69% | 29,99% | ** |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 86,400000 | 28/08/2026 | 21,88% | 33,31% | ** |
| JPM TOTAL EMERGING MARKETS INCOME A (ACC) EUR | MIXTO AGRESIVO GLOBAL | 153,160000 | 28/08/2026 | 14,41% | 42,43% | ***** |
| JPM TOTAL EMERGING MARKETS INCOME A (ACC) USD | MIXTO AGRESIVO GLOBAL | 153,079103 | 28/08/2026 | 14,63% | 42,47% | ***** |
| JPM TOTAL EMERGING MARKETS INCOME A (DIST) EUR | MIXTO AGRESIVO GLOBAL | 110,470000 | 28/08/2026 | 14,41% | 29,86% | ** |
| JPM TOTAL EMERGING MARKETS INCOME A (DIV) EUR | MIXTO AGRESIVO GLOBAL | 107,690000 | 28/08/2026 | 9,72% | 20,27% | * |
| JPM TOTAL EMERGING MARKETS INCOME C (ACC) EUR | MIXTO AGRESIVO GLOBAL | 174,510000 | 28/08/2026 | 14,98% | 45,68% | ***** |
| JPM TOTAL EMERGING MARKETS INCOME D (ACC) EUR | MIXTO AGRESIVO GLOBAL | 140,790000 | 28/08/2026 | 13,92% | 39,69% | **** |
| JPM TOTAL EMERGING MARKETS INCOME D (ACC) USD | MIXTO AGRESIVO GLOBAL | 140,831401 | 28/08/2026 | 14,15% | 39,72% | **** |
| JPM TOTAL EMERGING MARKETS INCOME D (DIV) EUR | MIXTO AGRESIVO GLOBAL | 73,890000 | 28/08/2026 | 9,24% | 17,92% | * |
| JPM TOTAL EMERGING MARKETS INCOME I2 (ACC) EUR | MIXTO AGRESIVO GLOBAL | 146,610000 | 28/08/2026 | 15,11% | · | ND |
| JPM TOTAL EMERGING MARKETS INCOME I2 (ACC) EUR (HEDGED) | MIXTO AGRESIVO GLOBAL | 142,160000 | 28/08/2026 | 12,58% | 47,50% | **** |
| JPM TOTAL EMERGING MARKETS INCOME I (DIST) EUR (HEDGED) | MIXTO AGRESIVO GLOBAL | 121,620000 | 28/08/2026 | 12,49% | 29,00% | ** |
| JPM US AGGREGATE BOND A (ACC) EUR (HEDGED) | RFI USA | 76,560000 | 28/08/2026 | -1,71% | 6,08% | ** |